Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities

Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities
Author(s)/Editor(s): Dimple Sethi Chopra (Punjabi University, India) and Ankur Kaul (Institute of Nuclear Medicine and Allied Sciences, India)
Copyright: ©2021
DOI: 10.4018/978-1-7998-0307-2
ISBN13: 9781799803072
ISBN10: 1799803074
EISBN13: 9781799803096


View Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities on the publisher's website for pricing and purchasing information.


Recently, there has been an upsurge in microbial infections. Extensive and inappropriate usage of antimicrobial drugs in treating infections has led to the evolution of a resistant strain of microorganisms and irreversible immunosuppression in humans. Medical institutions and hospitals require solutions to combat these contagions in order to avoid future epidemics.

Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities highlights current research and potential strategies to prevent the emergence and re-emergence of drug-resistant pathogenic microbial strains. The content within this publication examines biosensing, global initiatives, nanomaterials, and alternative therapies. It is designed for microbiologists, biotechnologists, pharmacists, pharmacologists, virologists, formulation scientists, infectious disease specialists, government officials, policymakers, healthcare practitioners, doctors, nurses, hospital directors, researchers, surgeons, and academicians who are seeking research on innovative solutions for multi-drug-resistant infections.

Author's/Editor's Biography

Ankur Kaul (Ed.)

Ankur Kaul is a pharmacist by profession with a blend of expertise in basic as well as radio-pharmaceutical research. She has acquired multi-disciplinary qualification with her Bachelor's degree in Pharmacy from Mumbai University, Master’s Degree in Bioinformatics and Ph.D. (Life Science). After a brief stint of working at pharmaceutical companies like Novartis India ltd. and FDC India ltd, she joined INMAS, DRDO in year 2006. She is AERB-certified Radiation Safety Officer (RSO) for biomedical research and is faculty- member for Diploma in Radiation Medicine course (affiliated to University of Delhi) for PG MBBS students. She is also nominated as General Secretary for INMAS-Institutional Human Ethics Committee. Her research interests are radiopharmaceuticals-development for diagnostic application which includes radiolabeling of drugs and nano-particles and their preclinical evaluation. She has successfully developed and translated a ‘diagnostic kit formulation’ from mouse to man for application in early detection of infection. Her research contribution is recognized over 30 international peer-reviewed journals and is life-member of professional bodies like Indian Pharmaceutical Association (IPA) and Society of Nuclear Medicine, India (SNMI) and Delhi Pharmacy Council (DPC) and Indian Society of Nanomedicine (ISNM).


Body Bottom